Author
Listed:
- L. Orliaguet
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory)
- T. Ejlalmanesh
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory)
- A. Humbert
(Lyon 1 University)
- R. Ballaire
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory)
- M. Diedisheim
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory
Assistance Publique - Hôpitaux de Paris, Université Paris Cité)
- J. B. Julla
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory
Université Paris Cité)
- D. Chokr
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory)
- J. Cuenco
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory)
- J. Michieletto
(Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), MetaboHUB)
- J. Charbit
(Service d’endocrinologie, diabétologie, maladies métaboliques, Hôpital Avicenne)
- D. Lindén
(BioPharmaceuticals R&D, AstraZeneca)
- J. Boucher
(BioPharmaceuticals R&D, AstraZeneca)
- C. Potier
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory)
- A. Hamimi
(Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory)
- S. Lemoine
(INSERM, Université PSL)
- C. Blugeon
(INSERM, Université PSL)
- P. Legoix
(PSL University)
- S. Lameiras
(PSL University)
- L. G. Baudrin
(PSL University)
- S. Baulande
(PSL University)
- A. Soprani
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory
Geoffroy Saint Hilaire Clinic)
- F. A. Castelli
(Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), MetaboHUB)
- F. Fenaille
(Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), MetaboHUB)
- J. P. Riveline
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory
Université Paris Cité)
- E. Dalmas
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory)
- J. Rieusset
(Lyon 1 University)
- J. F. Gautier
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory
Université Paris Cité)
- N. Venteclef
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory)
- F. Alzaid
(Université Paris Cité, Institut Necker Enfants Malades
Université Paris Cité, Sorbonne Université, Centre de Recherche des Cordeliers, IMMEDIAB Laboratory
Dasman Diabetes Institute)
Abstract
Adipose tissue macrophages (ATM) adapt to changes in their energetic microenvironment. Caloric excess, in a range from transient to diet-induced obesity, could result in the transition of ATMs from highly oxidative and protective to highly inflammatory and metabolically deleterious. Here, we demonstrate that Interferon Regulatory Factor 5 (IRF5) is a key regulator of macrophage oxidative capacity in response to caloric excess. ATMs from mice with genetic-deficiency of Irf5 are characterised by increased oxidative respiration and mitochondrial membrane potential. Transient inhibition of IRF5 activity leads to a similar respiratory phenotype as genomic deletion, and is reversible by reconstitution of IRF5 expression. We find that the highly oxidative nature of Irf5-deficient macrophages results from transcriptional de-repression of the mitochondrial matrix component Growth Hormone Inducible Transmembrane Protein (GHITM) gene. The Irf5-deficiency-associated high oxygen consumption could be alleviated by experimental suppression of Ghitm expression. ATMs and monocytes from patients with obesity or with type-2 diabetes retain the reciprocal regulatory relationship between Irf5 and Ghitm. Thus, our study provides insights into the mechanism of how the inflammatory transcription factor IRF5 controls physiological adaptation to diet-induced obesity via regulating mitochondrial architecture in macrophages.
Suggested Citation
L. Orliaguet & T. Ejlalmanesh & A. Humbert & R. Ballaire & M. Diedisheim & J. B. Julla & D. Chokr & J. Cuenco & J. Michieletto & J. Charbit & D. Lindén & J. Boucher & C. Potier & A. Hamimi & S. Lemoin, 2022.
"Early macrophage response to obesity encompasses Interferon Regulatory Factor 5 regulated mitochondrial architecture remodelling,"
Nature Communications, Nature, vol. 13(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-32813-z
DOI: 10.1038/s41467-022-32813-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-32813-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.